Abstract
Background: Due to the increasing number of diabetes cases worldwide, there is an international concern to provide even more effective treatments to control this condition.
Methods: This review brings together a selection of studies that helped to broaden the comprehension of various biological targets and associated mechanisms involved in type 2 diabetes mellitus.
Results: Such studies demonstrated that QSAR techniques and virtual screenings have been successfully employed in drug design projects.
Conclusions: Therefore, the main goal of this review is to give the state-of-art for the development of new drugs for the treatment of type 2 diabetes mellitus and to evaluate how computational tools, such as virtual screening and 3D-QSAR, can aid the development of new drugs with reduced adverse side effects.
Keywords: Biological targets, computational chemistry, diabetes, drug design, QSAR, virtual screening.
Graphical Abstract
Medicinal Chemistry
Title:The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery
Volume: 13 Issue: 8
Author(s): Simone Q. Pantaleao, Drielli G.V. Fujii, Vinicius G. Maltarollo, Danielle da C. Silva, Gustavo H.G. Trossini, Karen C. Weber, Luis P.B. Scott and Kathia M. Honorio*
Affiliation:
- School of Arts, Sciences and Humanities, University of Sao Paulo, 03828-000, Sao Paulo, SP,Brazil
Keywords: Biological targets, computational chemistry, diabetes, drug design, QSAR, virtual screening.
Abstract: Background: Due to the increasing number of diabetes cases worldwide, there is an international concern to provide even more effective treatments to control this condition.
Methods: This review brings together a selection of studies that helped to broaden the comprehension of various biological targets and associated mechanisms involved in type 2 diabetes mellitus.
Results: Such studies demonstrated that QSAR techniques and virtual screenings have been successfully employed in drug design projects.
Conclusions: Therefore, the main goal of this review is to give the state-of-art for the development of new drugs for the treatment of type 2 diabetes mellitus and to evaluate how computational tools, such as virtual screening and 3D-QSAR, can aid the development of new drugs with reduced adverse side effects.
Export Options
About this article
Cite this article as:
Pantaleao Q. Simone , Fujii G.V. Drielli , Maltarollo G. Vinicius , da C. Silva Danielle , Trossini H.G. Gustavo, Weber C. Karen, Scott P.B. Luis and Honorio M. Kathia *, The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery, Medicinal Chemistry 2017; 13 (8) . https://dx.doi.org/10.2174/1573406413666170522152102
DOI https://dx.doi.org/10.2174/1573406413666170522152102 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Utility of Biomarkers in Premature Atherosclerosis
Current Medicinal Chemistry Disorder in Milk Proteins: α -Lactalbumin. Part A. Structural Properties and Conformational Behavior
Current Protein & Peptide Science Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives
Current Medicinal Chemistry Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design The Antidiabetic Therapeutic Potential of Dietary Polyphenols
Current Pharmaceutical Biotechnology Applications of Random Walk Model on Biological Networks
Current Bioinformatics The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) Bioartificial Pancreas: Drug Delivery through Islet Microencapsulation to Treat Diabetes
Recent Patents on Biomedical Engineering (Discontinued) Recent Patents and Advances in Hepatocyte-Like Cells Differentiation by Perinatal Stem Cells
Recent Patents on Regenerative Medicine Editorial from Editor-in-Chief: Hypoglossal Nerve Stimulation: An Emerging and Futuristic Therapy for Obstructive Sleep Apnea
Current Respiratory Medicine Reviews The Burden of Cardiovascular Disease Risk Factors in the Middle East: A Systematic Review and Meta-Analysis Focusing on Primary Prevention
Current Vascular Pharmacology An Updated Review for the Diabetic Wound Healing Systems
Current Drug Targets Synergistic Two-Way Interactions of Dietary Polyphenols and Dietary Components on the Gut Microbial Composition: Is There a Positive, Negative, or Neutralizing Effect in the Prevention and Management of Metabolic Diseases?
Current Protein & Peptide Science Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Proteomic Profiling of Maternal Serum for Early Risk Analysis of Preterm Birth
Current Proteomics Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development)
Current Pharmaceutical Design Thrombomodulin Links Coagulation to Inflammation and Immunity
Current Drug Targets Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Current Medicinal Chemistry Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia
Current Diabetes Reviews Chymase Inhibitors
Current Pharmaceutical Design